(Q40743909)

23 September 2017

Ceftazidime with or without amikacin for the empiric treatment of localized infections in febrile, granulocytopenic patients (English)

1 reference

23 September 2017

1 reference

1 reference

I R Nováková

1

1 reference

23 September 2017

J P Donnelly

series ordinal

2

1 reference

23 September 2017

B E de Pauw

series ordinal

3

1 reference

23 September 2017

1 October 1991

1 reference

23 September 2017

1 reference

23 September 2017

63

1 reference

23 September 2017

195-200

1 reference

23 September 2017

4

1 reference

Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

23 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FBF01703442

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01703442

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01703442

Ceftazidime as monotherapy or combined with teicoplanin for initial empiric treatment of presumed bacteremia in febrile granulocytopenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01703442

A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01703442

Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01703442

Increased aminoglycoside dosage requirements in hematologic malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01703442

Ceftazidime alone for treating Pseudomonas aeruginosa septicaemia in neutropenic patients

21 January 2018

1 reference

12 December 2020

Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia

1 reference

12 December 2020

Ceftazidime as first-line therapy for fever in acute leukaemia

1 reference

12 December 2020

After empiric therapy: what to do until the granulocyte comes back

1 reference

12 December 2020

Concept of empiric therapy with antibiotic combinations. Indications and limits

1 reference

12 December 2020

Towards individually tailored empiric antibiotic therapy in febrile granulocytopenic patients

1 reference

12 December 2020

Neutropenia, fever, and infection

1 reference

12 December 2020

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

1 reference

12 December 2020

A 10-year survey of clinically significant blood culture isolates and antibiotic susceptibilities from adult patients with hematological diseases at a major Swedish hospital

1 reference

12 December 2020

Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01703442

1 reference

release_pb2bkeqw7fbtrjky6e6ofuzpbe

23 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pb2bkeqw7fbtrjky6e6ofuzpbe

24 November 2022

mapped directly with Wikidata item

1 reference